Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
By TOM MURPHY, AP Health Writer Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out … Continued